We are live on ! Find out more
LDB

Lee, Danner & Bass Portfolio holdings

AUM $1.73B
1-Year Est. Return 36.69%
This Fund
S&P 500
This Quarter Est. Return
-3.43%
1 Year Est. Return
+36.69%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$946M
AUM Growth
-$44M
Cap. Flow
+$8.28M
Cap. Flow %
0.88%
Top 10 Hldgs %
42.21%
Holding
201
New
3
Increased
53
Reduced
78
Closed
4

Sector Composition

Rank Sector Weight
1 Financials 26.34%
2 Healthcare 17.8%
3 Technology 15.2%
4 Industrials 9.83%
5 Consumer Discretionary 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWM icon
176
iShares Russell 2000 ETF
IWM
$78.5B
$277K 0.03%
1,682
-45
-3% -$8.21K
SJM icon
177
J.M. Smucker
SJM
$12.9B
$273K 0.03%
1,985
VNQ icon
178
Vanguard Real Estate ETF
VNQ
$37.4B
$267K 0.03%
3,331
AMAT icon
179
Applied Materials
AMAT
$362B
$225K 0.02%
2,743
+40
+1% +$3.86K
VXF icon
180
Vanguard Extended Market ETF
VXF
$30.9B
$219K 0.02%
1,725
VIG icon
181
Vanguard Dividend Appreciation ETF
VIG
$112B
$216K 0.02%
1,600
FOX icon
182
Fox Class B
FOX
$24.6B
$215K 0.02%
7,528
-200
-3% -$6.27K
CRM icon
183
Salesforce
CRM
$204B
$212K 0.02%
1,471
PAAS icon
184
Pan American Silver
PAAS
$20.9B
$191K 0.02%
12,000
+2,000
+20% +$34.8K
AGI icon
185
Alamos Gold
AGI
$15B
$163K 0.02%
22,000
+2,000
+10% +$14.8K
SXC icon
186
SunCoke Energy
SXC
$850M
$145K 0.02%
25,000
VTRS icon
187
Viatris
VTRS
$19B
$127K 0.01%
14,909
-323
-2% -$3.18K
KGC icon
188
Kinross Gold
KGC
$34.6B
$81K 0.01%
21,466
NWBO
189
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
$14K ﹤0.01%
20,000
PVCT
190
DELISTED
PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT
$2K ﹤0.01%
50,000
FXI icon
191
iShares China Large-Cap ETF
FXI
$4.11B
-60,075
Closed -$2.04M
OGN icon
192
Organon & Co
OGN
$3.58B
-8,661
Closed -$292K

Similar funds

Lee, Danner & Bass's Q3 2022 Portfolio in Review

As of Q3 2022, Lee, Danner & Bass held 201 positions worth $946M, down 4.4% from $990M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 3.5%. Lee, Danner & Bass opened 3 new positions and exited 4, leaving the 201-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Technology.

  • Lee, Danner & Bass's largest Q3 2022 buy was Simplify Health Care ETF: 113,528 shares worth $2.7M.
  • Lee, Danner & Bass added most to Cable One in Q3 2022, an estimated $1.79M increase.
  • Lee, Danner & Bass's biggest Q3 2022 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $1.75M.
  • Lee, Danner & Bass fully exited iShares China Large-Cap ETF in Q3 2022, selling an estimated $2.04M.
  • Lee, Danner & Bass's ten largest holdings make up 42% of its $946M portfolio in Q3 2022.
  • Lee, Danner & Bass opened 3 new positions and closed 4 in Q3 2022.
  • Lee, Danner & Bass's portfolio value fell 4.4% quarter-over-quarter to $946M.

Based on Lee, Danner & Bass's 13F filing for Q3 2022, filed 31 Oct 2022.